Proteomic biomarkers of Kleine-Levin syndrome
© The Author(s) 2022. Published by Oxford University Press on behalf of Sleep Research Society. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com..
STUDY OBJECTIVES: Kleine-Levin syndrome (KLS) is characterized by relapsing-remitting episodes of hypersomnia, cognitive impairment, and behavioral disturbances. We quantified cerebrospinal fluid (CSF) and serum proteins in KLS cases and controls.
METHODS: SomaScan was used to profile 1133 CSF proteins in 30 KLS cases and 134 controls, while 1109 serum proteins were profiled in serum from 26 cases and 65 controls. CSF and serum proteins were both measured in seven cases. Univariate and multivariate analyses were used to find differentially expressed proteins (DEPs). Pathway and tissue enrichment analyses (TEAs) were performed on DEPs.
RESULTS: Univariate analyses found 28 and 141 proteins differentially expressed in CSF and serum, respectively (false discovery rate <0.1%). Upregulated CSF proteins included IL-34, IL-27, TGF-b, IGF-1, and osteonectin, while DKK4 and vWF were downregulated. Pathway analyses revealed microglial alterations and disrupted blood-brain barrier permeability. Serum profiles show upregulation of Src-family kinases (SFKs), proteins implicated in cellular growth, motility, and activation. TEA analysis of up- and downregulated proteins revealed changes in brain proteins (p < 6 × 10-5), notably from the pons, medulla, and midbrain. A multivariate machine-learning classifier performed robustly, achieving a receiver operating curve area under the curve of 0.90 (95% confidence interval [CI] = 0.78-1.0, p = 0.0006) in CSF and 1.0 (95% CI = 1.0-1.0, p = 0.0002) in serum in validation cohorts, with some commonality across tissues, as the model trained on serum sample also discriminated CSF samples of controls versus KLS cases.
CONCLUSIONS: Our study identifies proteomic KLS biomarkers with diagnostic potential and provides insight into biological mechanisms that will guide future research in KLS.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
|---|---|
| Enthalten in: |
Sleep - 45(2022), 9 vom: 08. Sept. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hédou, Julien [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Aptamers |
|---|
| Anmerkungen: |
Date Completed 09.09.2022 Date Revised 22.07.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/sleep/zsac097 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM343793849 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM343793849 | ||
| 003 | DE-627 | ||
| 005 | 20231226021255.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/sleep/zsac097 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1145.xml |
| 035 | |a (DE-627)NLM343793849 | ||
| 035 | |a (NLM)35859339 | ||
| 035 | |a (PII)zsac097 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hédou, Julien |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Proteomic biomarkers of Kleine-Levin syndrome |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.09.2022 | ||
| 500 | |a Date Revised 22.07.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Author(s) 2022. Published by Oxford University Press on behalf of Sleep Research Society. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com. | ||
| 520 | |a STUDY OBJECTIVES: Kleine-Levin syndrome (KLS) is characterized by relapsing-remitting episodes of hypersomnia, cognitive impairment, and behavioral disturbances. We quantified cerebrospinal fluid (CSF) and serum proteins in KLS cases and controls | ||
| 520 | |a METHODS: SomaScan was used to profile 1133 CSF proteins in 30 KLS cases and 134 controls, while 1109 serum proteins were profiled in serum from 26 cases and 65 controls. CSF and serum proteins were both measured in seven cases. Univariate and multivariate analyses were used to find differentially expressed proteins (DEPs). Pathway and tissue enrichment analyses (TEAs) were performed on DEPs | ||
| 520 | |a RESULTS: Univariate analyses found 28 and 141 proteins differentially expressed in CSF and serum, respectively (false discovery rate <0.1%). Upregulated CSF proteins included IL-34, IL-27, TGF-b, IGF-1, and osteonectin, while DKK4 and vWF were downregulated. Pathway analyses revealed microglial alterations and disrupted blood-brain barrier permeability. Serum profiles show upregulation of Src-family kinases (SFKs), proteins implicated in cellular growth, motility, and activation. TEA analysis of up- and downregulated proteins revealed changes in brain proteins (p < 6 × 10-5), notably from the pons, medulla, and midbrain. A multivariate machine-learning classifier performed robustly, achieving a receiver operating curve area under the curve of 0.90 (95% confidence interval [CI] = 0.78-1.0, p = 0.0006) in CSF and 1.0 (95% CI = 1.0-1.0, p = 0.0002) in serum in validation cohorts, with some commonality across tissues, as the model trained on serum sample also discriminated CSF samples of controls versus KLS cases | ||
| 520 | |a CONCLUSIONS: Our study identifies proteomic KLS biomarkers with diagnostic potential and provides insight into biological mechanisms that will guide future research in KLS | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a CSF | |
| 650 | 4 | |a Kleine–Levine syndrome | |
| 650 | 4 | |a aptamers | |
| 650 | 4 | |a brain immunity | |
| 650 | 4 | |a hypersomnia | |
| 650 | 4 | |a microglia | |
| 650 | 4 | |a proteomics | |
| 650 | 4 | |a serum | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 700 | 1 | |a Cederberg, Katie L |e verfasserin |4 aut | |
| 700 | 1 | |a Ambati, Aditya |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Ling |e verfasserin |4 aut | |
| 700 | 1 | |a Farber, Neal |e verfasserin |4 aut | |
| 700 | 1 | |a Dauvilliers, Yves |e verfasserin |4 aut | |
| 700 | 1 | |a Quadri, Mohammed |e verfasserin |4 aut | |
| 700 | 1 | |a Bourgin, Patrice |e verfasserin |4 aut | |
| 700 | 1 | |a Plazzi, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Andlauer, Olivier |e verfasserin |4 aut | |
| 700 | 1 | |a Hong, Seung-Chul |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Yu-Shu |e verfasserin |4 aut | |
| 700 | 1 | |a Leu-Semenescu, Smaranda |e verfasserin |4 aut | |
| 700 | 1 | |a Arnulf, Isabelle |e verfasserin |4 aut | |
| 700 | 1 | |a Taheri, Shahrad |e verfasserin |4 aut | |
| 700 | 1 | |a Mignot, Emmanuel |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Sleep |d 1986 |g 45(2022), 9 vom: 08. Sept. |w (DE-627)NLM00225574X |x 1550-9109 |7 nnns |
| 773 | 1 | 8 | |g volume:45 |g year:2022 |g number:9 |g day:08 |g month:09 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/sleep/zsac097 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 45 |j 2022 |e 9 |b 08 |c 09 | ||